Drug Information

Drug General Information
Drug ID
D09TCY
Former ID
DNCL002548
Drug Name
CDX-1401
Indication Solid tumours [ICD9: 140-199, 210-229; ICD10:C00-D48] Phase 2 [524740]
Company
Celldex Therapeutics
Target and Pathway
Target(s) NY-ESO-1 Target Info Modulator [550444]
References
Ref 524740ClinicalTrials.gov (NCT02129075) CDX-1401 and Poly-ICLC Vaccine Therapy With or Without CDX-301in Treating Patients With Stage IIB-IV Melanoma. U.S. National Institutes of Health.
Ref 550444National Cancer Institute Drug Dictionary (drug id 651880).